Navigation Links
ACUVUE OASYS with HYDRACLEAR™ PLUS

ProductsACUVUE OASYS with HYDRACLEAR™ PLUS
Company Vistakon, a Johnson & Johnson Company
Item ACUVUE OASYS with HYDRACLEAR™ PLUS
Features 
  • Feels almost like youre wearing no lens at all
  • Helps soothe the discomfort from eyes feeling tired and dry
  • Reduces the need for rewetting drops
  • Contains HYDRACLEAR PLUS the next generation of proprietary technology that creates a more wettable, ultra smooth contact lens
  • Visibility tint so your lenses are easy to see and handle
  • Highest UVA and UVB Blocking to help protect against harmful UV rays, blocking 96% of UV-A rays and 99% of UV-B rays
  • Inside-Out Mark so youll insert your lenses correctly every time
  • 100% Satisfaction Guarantee
  • Made by Johnson & Johnson Vision Care, Inc.
Description Today's environments can create tired, dry eyes. With ACUVUE OASYS IN, Dry is OUT. Whether youre inside or outside, challenging environments can make your eyes feel tired and dry. Even long hours in front of a computer can leave your eyes craving moisture. Find relief with ACUVUE OASYS with HYDRACLEAR PLUS Brand Contact Lenses. It will almost feel like youre wearing no lens at all.
Info Vistakon, a Johnson & Johnson Company
Customer Service: (800) 843-2020
Web site: http://www.acuvue.com/

Related medicine products :

1. The EXTENDED FIT
2. Surgicel Fibrillar Absorbable Hemostat (oxidized regenerated cellulose)
3. Surgicel Absorbable Hemostat Family
4. Surgicel NU-KNIT Absorbable Hemostat (oxidized regenerated cellulose)
5. Surgicel Nu-Knit Absorbable Hemostat
6. PHANTOM Absorbable Cannulated Interference Screws
7. ABSOLUTE Absorbable Cannulated Interference Screws
8. BioScrew® Bio-Absorbable Interference Screws
9. TwinFix AB Absorbable Suture Anchor
10. INSTAT Collagen Absorbable Hemostat
11. POLY GIA™ 75 - .060 (Single Use Stapler with Absorbable Staples)
The Natural Selection family of specialty allografts is spinal concepts response to surgeon requests for spinal allograft devices to eliminate the need for painful autograft harvesting....
Transcranial vascular DWL doppler....
Transcranial vascular DWL doppler....
... Neurocare is a full-featured physiologic testing system offered ... contains many of the features of our flagship ... economical price. , ,The smaller size of the ... environment, the physician's office, a mobile service or ...
Medicine Products:
(Date:8/31/2015)... ... August 31, 2015 , ... The Lisle family law ... William Scott has been nominated by his peers to earn a “Leading Lawyers” distinction. ... percent of attorneys in the state of Illinois. The nomination process is based on ...
(Date:8/31/2015)... ... August 31, 2015 , ... Patients who thought about getting ... are interested in learning more about the procedure beyond the information found on the ... recognized hair transplant surgeon Parsa Mohebi will be on hand to answer patients hair ...
(Date:8/31/2015)... ... 01, 2015 , ... Neuropsychiatric Disease and Treatment ... transcranial near-infrared laser phototherapy ”. , As corresponding author Dr Theodore Henderson says ... - with mostly palliative treatments only - and now we have shown real ...
(Date:8/31/2015)... ... ... Dr. Paul Kovatis of Orthopedic Spine & Sports Medicine Center is celebrating ... surgical and non-surgical disorders of the leg, ankle and foot. He also specializes ... , Dr. Paul Kovatis completed his orthopedic leg, ankle and foot fellowship training at ...
(Date:8/31/2015)... , ... August 31, 2015 , ... ... digital marketing communications company announced today that it has officially launched a new ... the new website and brand refresh are more closely aligned with the company’s ...
Breaking Medicine News(10 mins):Health News:DuPage County Family Law Attorney Named Illinois Leading Lawyer 2Health News:Watch a Live Hair Transplant at Parsa Mohebi Hair Restoration’s Open House 2Health News:Near-Infrared Laser Phototherapy for Brain Injury published by Dove Medical Press 2Health News:Near-Infrared Laser Phototherapy for Brain Injury published by Dove Medical Press 3Health News:NJ Top Docs Presents, Dr. Paul Kovatis of Orthopedic Spine & Sports Medicine Center on his Five Year Anniversary as an "NJ Top Doc" 2Health News:Diablo Publications Launches New Company Website 2Health News:Diablo Publications Launches New Company Website 3
... NARSAD: The Brain and Behavior Research Fund awards $12.6 ... the most promising ideas to lead to breakthroughs in ... from leading research institutions on six continents have been ... Investigator grant awards to support their innovative research. Since ...
... HealthDay Reporter , THURSDAY, Jan. 6 (HealthDay News) -- Crying ... some space: A new study indicates the smell of women,s ... scientists examining the significance of emotional human tears suggests they ... the eyes. Women,s tears play a functional role by emitting ...
... Alan Mozes HealthDay Reporter , THURSDAY, Jan. 6 ... wounded trauma patients intravenous (IV) fluids before bringing them ... death, a new study suggests. The finding flies in ... some states that require that IV fluids be given to ...
... that relies on thousands of synthetic molecules to fish for ... Alzheimer,s disease with a simple blood test. The same methodology ... to the report in the January 7th issue of the ... this works in Alzheimer,s disease, it suggests it is a ...
... on reactive oxygen species (ROS) ions or very small ... they damage cell structure and their potential link to stroke, ... Eli and Edythe Broad Center of Regenerative Medicine and Stem ... stem cells, the cells that give rise to neurons, maintain ...
... 2010 Researchers at Wofford College discovered that a Border ... names of objects and orders to fetch them. This research ... a dog that knew the names of a couple of ... far a dog could go, and whether the dog really ...
Cached Medicine News:Health News:NARSAD announces $12.6 million for new generation of brain and behavior research 2Health News:Women's Tears Tell Men to Back Off 2Health News:Giving IV Fluids on Scene Might Raise Death Risk for Trauma Victims 2Health News:Giving IV Fluids on Scene Might Raise Death Risk for Trauma Victims 3Health News:A blood test for Alzheimer's disease? 2Health News:A blood test for Alzheimer's disease? 3Health News:Neural stem cells maintain high levels of reactive oxygen species, UCLA study finds 2Health News:Neural stem cells maintain high levels of reactive oxygen species, UCLA study finds 3Health News:Border collie comprehends over 1,000 object names 2Health News:Border collie comprehends over 1,000 object names 3
(Date:8/31/2015)... 31, 2015  Asterias Biotherapeutics, Inc. (NYSE MKT: ... field of regenerative medicine, today announced that the ... Chicago -based Rush University Medical Center in ... escalating doses of AST-OPC1 (oligodendrocyte progenitor cells) in ... cervical spinal cord injury (SCI). This represents the ...
(Date:8/31/2015)... 2015   BioLife Solutions , Inc. (NASDAQ: ... marketer of proprietary clinical grade cell and tissue ... media and a related cloud hosted ... smart shippers ("BioLife" or the "Company"), today ... biopharmaceutical company focused on developing and commercializing novel ...
(Date:8/28/2015)... , Aug. 28, 2015  With the heroin ... reaching deadlier heights, Jacksonville -based Lakeview ... Hemphill is helping to explain why fentanyl is ... approximately 40 to 50 times more potent than pharmaceutical ... users as heroin, the risk of death skyrockets. ...
Breaking Medicine Technology:Asterias Biotherapeutics Concludes Recruitment of Initial Safety Cohort of the SCiStar Phase 1/2a Dose-Escalation Clinical Trial of AST-OPC1 for Complete Cervical Spinal Cord Injury 2Asterias Biotherapeutics Concludes Recruitment of Initial Safety Cohort of the SCiStar Phase 1/2a Dose-Escalation Clinical Trial of AST-OPC1 for Complete Cervical Spinal Cord Injury 3Asterias Biotherapeutics Concludes Recruitment of Initial Safety Cohort of the SCiStar Phase 1/2a Dose-Escalation Clinical Trial of AST-OPC1 for Complete Cervical Spinal Cord Injury 4Asterias Biotherapeutics Concludes Recruitment of Initial Safety Cohort of the SCiStar Phase 1/2a Dose-Escalation Clinical Trial of AST-OPC1 for Complete Cervical Spinal Cord Injury 5Asterias Biotherapeutics Concludes Recruitment of Initial Safety Cohort of the SCiStar Phase 1/2a Dose-Escalation Clinical Trial of AST-OPC1 for Complete Cervical Spinal Cord Injury 6BioLife Solutions Customer TiGenix Phase 3 Clinical Trial Meets Primary Endpoint 2BioLife Solutions Customer TiGenix Phase 3 Clinical Trial Meets Primary Endpoint 3BioLife Solutions Customer TiGenix Phase 3 Clinical Trial Meets Primary Endpoint 4BioLife Solutions Customer TiGenix Phase 3 Clinical Trial Meets Primary Endpoint 5Lakeview Health's Dr. Philip Hemphill Explains Why Heroin Addicts Are Now Dying of Fentanyl Overdoses 2